Epithalon is generally well-suited for patients 35+ focusing on aging modulation, though younger patients may benefit in specific contexts
Reduced inflammation, improved tissue organization, and blood vessel formation become potentially visible on ultrasound or MRI
But the mechanism is well-characterized and the target (NNMT in adipose tissue) is a legitimate pathway for visceral fat reduction
A comprehensive history should also include menstrual and sexual history, medical history with emphasis on other chronic pain disorders (i.e., fibromyalgia, irritable bowel syndrome, migraines, endometriosis, vulvodynia, etc.), surgical history, medication use and allergies, and use of tobacco, alcohol, and drugs
Vial size: Supplied in a 3mL vial